Zhou Jin

Zhou Jin

Zhou Jin, male, graduated from the Fourth Military Medical University of the Chinese people's Liberation Army with a bachelor's degree in 1983, a master's degree in internal medicine of Harbin Medical University in 1992, a doctor's degree in hematology of Suzhou University in 1995, and a post doctoral mobile station in the national pharmacology base of Harbin Medical University in 1997.

He is now chairman of Heilongjiang Hematology Department of Chinese Medical Association, President of First Hospital of Harbin Medical University, director of information center of First Hospital of Harbin Medical University, director of experimental center of First Hospital of Harbin Medical University, director of blood tumor center of First Hospital of Harbin Medical University, director of Department of Hematology, doctoral supervisor and postdoctoral teacher. He is the judge of national and provincial natural fund and the evaluation expert of provincial science and technology progress award. He is the editor of Journal of Harbin Medical University He is also a member of the academic committee of Harbin Medical University and the first hospital of Harbin Medical University, one of the top ten famous doctors of the first hospital of Harbin Medical University, and a health care expert of Heilongjiang provincial cadres.

Character achievement

Professor Zhou Jin has rich clinical experience. He has successfully organized the health care work of provincial leaders, rescued the critically ill patients and determined the causes of difficult blood diseases. In the mechanism and treatment of acute leukemia research has a number of innovations and has been recognized by experts at home and abroad, in the treatment of other blood diseases research breakthrough, undertake two National Natural Science Foundation projects, an overseas major cooperation project, three provincial major scientific research projects, a Provincial Outstanding Youth Fund, a municipal science and Technology Commission key fund and "211" project fund Topic. He has won national and provincial science and technology progress awards for many times and edited three academic monographs. Its academic achievements include: Taking the lead in discovering the relationship between the intracellular arsenic trioxide concentration and the therapeutic sensitivity of tumor cells, providing theoretical basis for further targeted therapy, expanding the therapeutic indications of arsenic trioxide; taking the lead in discovering the adverse reaction mechanism of arsenic trioxide cardio cerebrovascular system and the molecular pharmacological mechanism of prolonging QT interval of electrocardiogram System, In order to prevent and reduce the early adverse reactions of arsenic trioxide in the treatment of leukemia, we invented the "arsenic trioxide fractional slow intravenous infusion method", which overcomes the hyperleukocytemia and DIC, which are easy to appear in the early stage of arsenic trioxide treatment and seriously affect the treatment effect. At the same time, this method makes some conventional methods of arsenic trioxide treatment effect is not ideal It is a good example of noninvasive monitoring and prevention of central nervous system leukemia.

Present position

President of the First Affiliated Hospital of Harbin Medical University, member of Hematology Committee of Chinese Medical Association, international member of American hematology Association, chairman of Hematology Committee of Heilongjiang Medical Association. Editorial board members of Chinese Journal of Hematology, Clinical Journal of Hematology and other journals, and chief editor of blood channel of medical reference daily, in charge of Ministry of health. He is now the president of the First Affiliated Hospital of Harbin Medical University.

Social Appointments

He is the chairman of Heilongjiang hematology Committee of Chinese Medical Association, the judge of national and provincial natural fund, the judge expert of provincial science and technology progress award, the editorial board member of Journal of Harbin Medical University, the member of Academic Committee of Harbin Medical University and the first hospital of Harbin Medical University, the top ten famous doctors of the first hospital of Harbin Medical University and the health care expert of Heilongjiang provincial cadres.

Technical expertise

He is good at diagnosis and treatment of various hematological diseases, especially hematopoietic stem cell transplantation, acute and chronic leukemia, myelodysplastic syndrome, multiple myeloma, lymphoma, anemia, DIC, TTP, hemorrhagic diseases and difficult hematological diseases. Baidu Encyclopedia content is shared by netizens. If you find that your data content is inaccurate or incomplete, you are welcome to use your own data service (free) to participate in the correction. Go to > > now